Curative Biosciences (Curative Biosciences) Enterprise Value : $0.05 Mil (As of May. 27, 2024)

Curative Biosciences Enterprise Value Chart

Curative Biosciences Annual Data
	Trend	Jun08	Jun09	Jun10	Jun11	Jun12	Jun13	Jun14	Jun15	Jun16	Jun17
Enterprise Value		Get a 7-Day Free Trial					1.21	13.67	10.13	6.58	1.79

Curative Biosciences Quarterly Data
	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18
Enterprise Value	Get a 7-Day Free Trial															0.63	1.79	5.50	5.03	4.64

Competitive Comparison of Curative Biosciences's Enterprise Value

For the Drug Manufacturers - Specialty & Generic subindustry, Curative Biosciences's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Curative Biosciences's Enterprise Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Curative Biosciences's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Curative Biosciences's Enterprise Value falls into.

Curative Biosciences Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Curative Biosciences's Enterprise Value for the fiscal year that ended in Jun. 2017 is calculated as

Curative Biosciences's Enterprise Value for the quarter that ended in Mar. 2018 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Curative Biosciences  (OTCPK:CBDX) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Curative Biosciences's EV-to-EBIT for today is

Curative Biosciences's current Enterprise Value is $0.05 Mil.
Curative Biosciences's EBIT for the trailing twelve months (TTM) ended in Mar. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.52 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Curative Biosciences's EV-to-EBITDA for today is:

Curative Biosciences's current Enterprise Value is $0.05 Mil.
Curative Biosciences's EBITDA for the trailing twelve months (TTM) ended in Mar. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.52 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Curative Biosciences's EV-to-Revenue for today is:

Curative Biosciences's current Enterprise Value is $0.05 Mil.
Curative Biosciences's Revenue for the trailing twelve months (TTM) ended in Mar. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Curative Biosciences Enterprise Value Related Terms

Thank you for viewing the detailed overview of Curative Biosciences's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Curative Biosciences (Curative Biosciences) Business Description